Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • The Inquiry Report
    • Additional Compensation Report
    • First Interim Report
    • Second Interim Report
    • Compensation Framework Study
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • NHS Psychological Support
    • Confidential Psychological Support
    • Support Groups
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
  • Contact us
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

In July 1983, Dr Aronstam wrote to Dr Evans which would have alerted him to the fact that Treloar's was undertaking AIDS related tests and looking for the stigmata of AIDS.

  • Read more about In July 1983, Dr Aronstam wrote to Dr Evans which would have alerted him to the fact that Treloar's was undertaking AIDS related tests and looking for the stigmata of AIDS.

There was no discernible change of approach in 1983 and 1984, the predominant treatment for the children at RMCH remained commercial concentrates, although NHS Factor 8 continued to be used as well.

  • Read more about There was no discernible change of approach in 1983 and 1984, the predominant treatment for the children at RMCH remained commercial concentrates, although NHS Factor 8 continued to be used as well.

There was no discernible change of approach in 1983 and 1984, the predominant treatment for the children at Royal Manchester Children's Hospital remained commercial concentrates, although NHS Factor 8 continued to be used as well.

  • Read more about There was no discernible change of approach in 1983 and 1984, the predominant treatment for the children at Royal Manchester Children's Hospital remained commercial concentrates, although NHS Factor 8 continued to be used as well.

Dr Evans wrote to Dr Aronstam stating he though it sensible that patients don't become too dependent on one manufacturer's concentrates.

  • Read more about Dr Evans wrote to Dr Aronstam stating he though it sensible that patients don't become too dependent on one manufacturer's concentrates.

Dr Evans wrote to Dr Aronstam declaring he did not think it mattered which product was used so long as the concentrate is changed "from time to time".

  • Read more about Dr Evans wrote to Dr Aronstam declaring he did not think it mattered which product was used so long as the concentrate is changed "from time to time".

Home treatment with an element of prophylaxis had been introduced in the early 1970s and families were advised some children may have an injection for a day, or for a period when bleeds are particularly troublesome.

  • Read more about Home treatment with an element of prophylaxis had been introduced in the early 1970s and families were advised some children may have an injection for a day, or for a period when bleeds are particularly troublesome.

Dr Evans said, treatment of cryoprecipitate was given to young patients with haemophilia rather than Factor VIII concentrates. The incidence of hepatitis was lower when using North Western Cryoprecipitate than imported concentrates. Concentrates were kept for home treatment versus cryoprecipitate for hospital treatment.

  • Read more about Dr Evans said, treatment of cryoprecipitate was given to young patients with haemophilia rather than Factor VIII concentrates. The incidence of hepatitis was lower when using North Western Cryoprecipitate than imported concentrates. Concentrates were kept for home treatment versus cryoprecipitate for hospital treatment.

Annual returns showed that there was no policy of restricting patients to single manufacturers or batches of commercial concentrate.

  • Read more about Annual returns showed that there was no policy of restricting patients to single manufacturers or batches of commercial concentrate.

At the Royal Manchester Children's Hospital, parents were unaware that their children were being tested for HIV.

  • Read more about At the Royal Manchester Children's Hospital, parents were unaware that their children were being tested for HIV.

By September 1982, Cryoprecipitate tended to be used for hospital treatment and concentrates for home treatment at the Royal Manchester Childrens' Hospital .

  • Read more about By September 1982, Cryoprecipitate tended to be used for hospital treatment and concentrates for home treatment at the Royal Manchester Childrens' Hospital .

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 14
  • Page 15
  • Page 16
  • Page 17
  • Current page 18
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.